An article from HealthLaw360.Com reports that the Food and Drug Administration advised Cephalon, Inc., maker of sleep disorder drug Provigil, to provide stronger warning label that would tell doctors not to recommend the drug to kids.

Provigil is one of the best-selling products of the drug company and is currently approved by the FDA for prescription by doctors to patients suffering from narcolepsy, shift work sleep disorder and sleep apnea. This is in view of the cases reported that the drug causes side effects like skin rush to children under 16 years of age.

This move by the FDA is laudable as it clearly shows that children safety is one of their priorities.

For the link to the article, click here.